FR2317912A1 - Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central - Google Patents

Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central

Info

Publication number
FR2317912A1
FR2317912A1 FR7621862A FR7621862A FR2317912A1 FR 2317912 A1 FR2317912 A1 FR 2317912A1 FR 7621862 A FR7621862 A FR 7621862A FR 7621862 A FR7621862 A FR 7621862A FR 2317912 A1 FR2317912 A1 FR 2317912A1
Authority
FR
France
Prior art keywords
acting
pharmaceutical composition
nervous system
central nervous
parenteral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7621862A
Other languages
English (en)
French (fr)
Other versions
FR2317912B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FR2317912A1 publication Critical patent/FR2317912A1/fr
Application granted granted Critical
Publication of FR2317912B1 publication Critical patent/FR2317912B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR7621862A 1975-07-16 1976-07-16 Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central Granted FR2317912A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/596,488 US4016273A (en) 1975-07-16 1975-07-16 Sustained release forms of certain oxazepines for parenteral administration

Publications (2)

Publication Number Publication Date
FR2317912A1 true FR2317912A1 (fr) 1977-02-11
FR2317912B1 FR2317912B1 (enExample) 1979-04-13

Family

ID=24387483

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7621862A Granted FR2317912A1 (fr) 1975-07-16 1976-07-16 Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central

Country Status (11)

Country Link
US (1) US4016273A (enExample)
BE (1) BE844203A (enExample)
CA (1) CA1062159A (enExample)
DE (1) DE2630394A1 (enExample)
DK (1) DK319776A (enExample)
FI (1) FI762053A7 (enExample)
FR (1) FR2317912A1 (enExample)
GB (1) GB1525425A (enExample)
NL (1) NL7607918A (enExample)
PT (1) PT65358B (enExample)
SE (1) SE7608114L (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002013870A3 (en) * 2000-08-17 2003-02-06 Apollo Biopharmaceutics Inc Formulation for administering therapeutic lipophilic molecules

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617321B2 (en) 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US6199634B1 (en) 1998-08-27 2001-03-13 Viatchelav Ivanovich Selyakov Method and apparatus for controlling the permeability of mineral bearing earth formations
ES2253375T3 (es) * 2000-04-19 2006-06-01 Genentech, Inc. Formulaciones de liberacion sostenida.
DE10059020A1 (de) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Parenteral applizierbare Darreichungsformen
PT1397155E (pt) * 2001-06-21 2015-12-07 Genentech Inc Formulação de libertação sustentada
US6972195B2 (en) * 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
KR20070006708A (ko) * 2004-01-07 2007-01-11 트라이머리스 인코퍼레이티드 ＨＩＶ ｇｐ41 ＨＲ2-유래된 합성 펩티드 및 인간 면역결핍바이러스의 전염을 저해하는 치료에서 이들의 용도
WO2006073886A1 (en) * 2005-01-05 2006-07-13 Eli Lilly And Company Olanzapine pamoate dihydrate
CN101415723B (zh) * 2006-02-02 2014-06-25 特里梅里斯公司 具有改良生物学特性的hiv融合抑制肽
EP1884507B1 (de) * 2006-07-27 2010-05-12 Cognis IP Management GmbH Verfahren zur Herstellung von Glycerin
EP2139526A4 (en) * 2007-04-03 2010-07-14 Trimeris Inc NEW FORMULATIONS TO RELEASE ANTIVIRAL PEPTIDE THERAPEUTICS
CA2700354A1 (en) * 2007-09-25 2009-04-02 Trimeris, Inc. Novel methods of synthesis for therapeutic antiviral peptides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3546226A (en) * 1963-03-01 1970-12-08 A Wander Sa Dr 11-basic-substituted dibenzoxazepines
US3663696A (en) * 1966-05-20 1972-05-16 American Cyanamid Co Treatment of depression with 2-chloro-11 - (piperazinyl)dibenz - (b,f)(1,4)oxazepines and acid addition salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3164520A (en) * 1962-10-29 1965-01-05 Olin Mathieson Injectable steroid compositions containing at least 75% benzyl benzoate
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
US3546220A (en) * 1966-08-01 1970-12-08 Abbott Lab 2,3-dihydro-1h-pyrido-(2,3-b)(1,4)thiazines
US3549621A (en) * 1968-04-29 1970-12-22 Harry Louis Yale 12-substituted-6h-dibenz(b,f)(1,4)oxazocin-11(12h) ones
US3891647A (en) * 1970-08-06 1975-06-24 Wander Ag Dr A 2-trifluoromethyl-sulphonyl-11-substituted-piperazinyl-dibenz {8 b,f{9 {8 1,4{9 {0 oxazepine
US3773768A (en) * 1970-10-26 1973-11-20 American Cyanamid Co 7-amino-2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine and salts thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3546226A (en) * 1963-03-01 1970-12-08 A Wander Sa Dr 11-basic-substituted dibenzoxazepines
US3663696A (en) * 1966-05-20 1972-05-16 American Cyanamid Co Treatment of depression with 2-chloro-11 - (piperazinyl)dibenz - (b,f)(1,4)oxazepines and acid addition salts thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002013870A3 (en) * 2000-08-17 2003-02-06 Apollo Biopharmaceutics Inc Formulation for administering therapeutic lipophilic molecules

Also Published As

Publication number Publication date
CA1062159A (en) 1979-09-11
FI762053A7 (enExample) 1977-01-17
GB1525425A (en) 1978-09-20
US4016273A (en) 1977-04-05
SE7608114L (sv) 1977-01-17
BE844203A (fr) 1977-01-17
PT65358B (en) 1978-01-09
DE2630394A1 (de) 1977-02-03
DK319776A (da) 1977-01-17
FR2317912B1 (enExample) 1979-04-13
PT65358A (en) 1976-08-01
NL7607918A (nl) 1977-01-18

Similar Documents

Publication Publication Date Title
BE849632A (fr) Composition pharmaceutique pour l'administration orale
HU171025B (hu) Sposob pokrytija steklovolokon, ispol'zuemykh pri armirovanii cementnykh izdelij
BE847283A (fr) Nouveaux medicaments derives de l'indole,
FR2317912A1 (fr) Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central
FR2321655A1 (fr) Moderateur de debit, notamment pour dispositifs d'injection intraveineuse
FR2333521A1 (fr) Dispositif d'administration d'un liquide par voie parenterale
RO69608A (ro) Procedeu pentru prepararea unor 1,2-benzizotiazol-3-one
BE838823A (fr) Procede pour la preparation de 1,2,5-dihydroxycholecalciferol
SU576021A3 (ru) Установка дл непрерывной разливки металлов
FR2335522A1 (fr) Procede de preparation d'androstene-4 diones-3,17
BE762232A (fr) Procede pour la preparation d'anilines n,n-dihaloalkyl-2,6- dinitro-4-substituees
FR2301976A1 (fr) Systeme de reglage pour le retablissement de l'ortho
ZA763977B (en) "4-imino-1,3-diazobicyclo(3.1.0)hexan-2-one"
RO76667A (ro) Procedeu pentru prepararea unor 2,4-dialchilamino-6-clor-5-triazine
PT64691B (fr) Procede pour la preparation d'acides 6,11-di-hydro-11-oxo-dibenz /b,e/ oxepin-alcanoiques
BE845017A (fr) Procede pour l'obtention d'alpha,alpha,alpha,alpha',alpha',-pentachloro-o-xylene
FR2335721A1 (fr) Cheville, notmment pour l'ameublement
FR2318166A1 (fr) Procede de preparation continue de 2,5-dioxo-1-oxa-2-phospholanes
DK138895B (da) Fremgangsmåde til fremstilling af 8-beta-(2'-pyrimidino-aminometyl)-ergolinderivater.
CA1035359A (en) 1-substituted-6,7-disubstituted-1,2,3,4-tetrahydroisoquinoline derivatives
BE810385A (fr) Compositions medicamenteuses pour l'administration par voie orale
PH10997A (en) 4-h-benzo(4,5)cyclochepta-(1,2-b)thiophen derivatives and pharmaceutical composition thereof
RO63736A (fr) Procede pour la preparation d'alcaloides m-formyldiindoliques
FR2314172A1 (fr) Procede pour la preparation d'aminoanthraquinones a partir de nitroanthraquinones
ZA747367B (en) 3,3a-dihydro-2h,9h-isoxazolo(3,2-b) (1,3) benzoxazin-9-ones

Legal Events

Date Code Title Description
ST Notification of lapse